Aims & Scope

Journal of Personalized NanoMedicine (JPNM) is an international peer reviewed official journal of the Society of Personalized NanoMedicine ( in the area of discoveries in nanotechnology and personalized NanoMedicine approach for biomedical application and at the point of care to improve the personalized health needs. The aims parallel that of the Society for Personalized NanoMedicine which is devoted to motivate young researchers, scientists and promote research & development by organizing conferences/symposiums and meetings focused on nanotechnology based personalized NanoMedicine and to disseminate informations that help to tailor intervention to patient and disease specific needs.
The scope of this journal is to provide a common platform that includes all primary and novel nanoscaled smart materials of unique properties and design/development of efficient nano drug carriers for delivery of therapeutic agents to target areas. Further, theoretical and experimental results of studies related to precision health care are also explored in this journal. JPNM invites original articles, editorials, commentary, prospectives, technical notes, commercialization notes, reviews, mini-reviews, communications, and research papers. Journal website also publishes news related to recent development in nanotechnology, diagnostics,imaging, theranostics and major breakthroughs in therapeutics, public health announcements and funding opportunities along with ethical issues.
JPNM covers various prospects of NanoMedicine, clinical applications, and diagnostics. The covered research areas in journal can be categorized mainly as smart nanomaterials, biomaterials, nanotechnology for biomedical application, nanotoxicity assessment, nano-drug formulation, methodologies for drug delivery, controlled drug delivery, custom designed therapeutics agents, imageguided therapeutics, personalized health care, personalized NanoMedicine, cross disciplinary approach in Personalized NanoMedicine, theoretical and experimental prospects and population  based studies for public health. Since JPNM is the official journal of the society, all the events associated with the society will be advertised in the journal web site in a timely fashion.
Coverage Including
  • Controlled, sustained & Site-specific drug delivery approaches
  • Novel Drug Delivery Systems (NDDS) using nanotechnology
  • Design, development and therapeutic application ofnew biomaterials
  • Nanotechnology to diagnostics tools &biomedical application
  • Nanotechnology for imaging & therapeutics application
  • Tissue, cell and genetic engineering involving nanomedicine tool
  • Nonmedicinal tools in gene therapy for inherited diseases
  • Nonmedical toxicology assessment and safety issue
  • Personalized nanomedicine for  health care and health monitoring
  • Medical nanotechnology and regenerative medicine for clinical disciplines
  • Advanced manufacturing for personalized Nanomedicine
  • Nanomedicine to eradicate CNS diseases
  • Personalizednanomedicine  in drug addiction
  • Bioinformaticstools &application for Personalized Nanomedicine
  • Nanotechnology for existing and emerging infectious diseases
  • Personalized Nanomedicine in drug development and drug resistance
  • Personalized nanomedicine approach  for the physicians at point of care
  • Personalized Nanomedicine forco-infections, integrated viralgenome or latent reservoirs
  • Cross disciplinary approach in personalized nanomedicine
  • Scientific and regulatory aspects in Personalized Nanomedicine
  • Ethical, regulatory and legal issues related to personalized nanomedicine